July 2024
1. YANG S, Liu R, Xin Z, Zhu Z, et al
   Plasma metabolomics identifies key metabolites and improves prediction of diabetic retinopathy: development and validation across multi-national cohorts.
   Ophthalmology. 2024 Jul 5:S0161-6420(24)00415.
   

   >> Share

   
   June 2024
2. ZARBIN M, Tabano D, Ahmed A, Amador M, et al
   Efficacy of Faricimab vs Aflibercept in Diabetic Macular Edema in the 20/50 or Worse Vision Subgroup in Phase 3 YOSEMITE/RHINE Trials.
   Ophthalmology. 2024 Jun 7:S0161-6420(24)00320.
   

   >> Share

   
   April 2024
3. WENG CY, Maguire MG, Flaxel CJ, Jain N, et al
   Effectiveness of Conventional Digital Fundus Photography-Based Teleretinal Screening for Diabetic Retinopathy and Diabetic Macular Edema: A Report by the American Academy of Ophthalmology.
   Ophthalmology. 2024 Apr 11:S0161-6420(24)00156.
   

   >> Share

   
   March 2024
4. NIAZI S, Gnesin F, Thein AS, Andreasen JR, et al
   Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes.
   Ophthalmology. 2024 Mar 8:S0161-6420(24)00171.
   

   >> Share

   
   February 2024
5. JHAVERI CD, Liu D, Maguire MG, Glassman AR, et al
   Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity <20/40.
   Ophthalmology. 2024 Feb 7:S0161-6420(24)00098.
   

   >> Share

   
   
6. WU Y, Egan C, Olvera-Barrios A, Scheppke L, et al
   Developing a Continuous Severity Scale for Macular Telangiectasia Type 2 Using Deep Learning and Implications for Disease Grading.
   Ophthalmology. 2024;131:219-226.
   

   >> Share

   
   January 2024
7. SAMMONS EL, Buck G, Bowman LJ, Stevens WM, et al
   ASCEND-Eye: Effects of Aspirin on Diabetic Retinopathy.
   Ophthalmology. 2024 Jan 16:S0161-6420(24)00056.
   

   >> Share

   
   
8. CHAUHAN MZ, Elhusseiny AM, Kishor KS, Sanvicente CT, et al
   Association of Primary Open-Angle Glaucoma with Diabetic Retinopathy Among Patients with Type 1 and Type 2 Diabetes: A Large Global Database Study.
   Ophthalmology. 2024 Jan 10:S0161-6420(24)00052.
   

   >> Share

   
   December 2023
9. WONG TY, Haskova Z, Asik K, Baumal CR, et al
   Faricimab Treat-and-Extend for Diabetic Macular Edema: 2-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
   Ophthalmology. 2023 Dec 27:S0161-6420(23)00933.
   

   >> Share

   
   
10. SAMMONS EL, Buck G, Bowman LJ, Stevens WM, et al
    ASCEND-Eye: Effects of Omega-3 Fatty Acids on Diabetic Retinopathy.
    Ophthalmology. 2023 Dec 3:S0161-6420(23)00870.
    

    >> Share

    
    
11. EHRLICH JR, Andes LJ, Eisenberg A, Saaddine J, et al
    Trends in the Diagnosed Prevalence and Incidence of Major Eye Diseases in Medicare Part B Fee-for-Service Beneficiaries 68 Years of Age or Older.
    Ophthalmology. 2023;130:1240-1247.
    

    >> Share

    
    June 2023
12. TACCHERI C, Jordan J, Tran D, Wang J, et al
    The impact of social determinants of health on eye care utilization in a national sample of people with diabetes.
    Ophthalmology. 2023 Jun 15:S0161-6420(23)00425.
    

    >> Share

    
    March 2023
13. REGILLO C, Berger B, Brooks L, Clark WL, et al
    Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results.
    Ophthalmology. 2023 Mar 2:S0161-6420(23)00135.
    

    >> Share

    
    February 2023
14. SHAKARCHI AF, Soliman MK, Yang YC, Sallam AB, et al
    Risk of Pseudophakic Cystoid Macular Edema in Fellow-Eye Cataract Surgeries: A Multicenter Database Study.
    Ophthalmology. 2023 Feb 3:S0161-6420(23)00063.
    

    >> Share

    
    December 2022
15. BAKER CW, Josic K, Maguire MG, Jampol LM, et al
    Comparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to eETDRS Protocol Visual Acuity Assessment.
    Ophthalmology. 2022 Dec 12:S0161-6420(22)00976.
    

    >> Share

    
    August 2022
16. LOIS N, Campbell C, Waugh N, Azuara-Blanco A, et al
    DIAbetic Macular Oedema aNd Diode Subthreshold micropulse laser (DIAMONDS): A randomized double-masked non-inferiority clinical trial.
    Ophthalmology. 2022 Aug 13. pii: S0161-6420(22)00631.
    

    >> Share

    
    
17. CHIA MA, Taylor JR, Stuart KV, Khawaja AP, et al
    Prevalence of diabetic retinopathy in Indigenous and non-Indigenous Australians: a systematic review and meta-analysis.
    Ophthalmology. 2022 Aug 2. pii: S0161-6420(22)00566.
    

    >> Share

    
    May 2022
18. MELLES RB, Marmor MF
    Rapid Macular Thinning is an Early Indicator of Hydroxychloroquine Retinal Toxicity.
    Ophthalmology. 2022 May 11. pii: S0161-6420(22)00335.
    

    >> Share

    
    January 2022
19. SINGER MA, Sheth V, Mansour SE, Coughlin B, et al
    Three-year safety and efficacy of the 0.19-mg fluocinolone acetonide intravitreal implant for diabetic macular edema: the PALADIN study.
    Ophthalmology. 2022 Jan 18. pii: S0161-6420(22)00067.
    

    >> Share

    
    October 2021
20. GONZALEZ VH, Wang PW, Ruiz CQ
    Panretinal Photocoagulation for Diabetic Retinopathy in the RIDE and RISE Trials: Not "1 and Done".
    Ophthalmology. 2021;128:1448-1457.
    

    >> Share

    
    June 2021
21. LENG T, Gallivan MD, Kras A, Lum F, et al
    Ophthalmology and COVID-19: The Impact of the Pandemic on Patient Care and Outcomes-an IRIS Registry Study.
    Ophthalmology. 2021 Jun 15. pii: S0161-6420(21)00455.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share